ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Down 48.4% in November

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 5,570,000 shares, a drop of 48.4% from the October 31st total of 10,800,000 shares. Approximately 12.3% of the company’s stock are sold short. Based on an average daily volume of 4,050,000 shares, the short-interest ratio is currently 1.4 days.

Analyst Upgrades and Downgrades

ASPI has been the subject of a number of analyst reports. Canaccord Genuity Group started coverage on ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company. Canaccord Genuity Group restated a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Finally, HC Wainwright dropped their price target on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a research note on Wednesday, August 7th.

Institutional Trading of ASP Isotopes

A number of institutional investors and hedge funds have recently modified their holdings of the business. The Manufacturers Life Insurance Company bought a new position in shares of ASP Isotopes during the third quarter valued at $52,000. Fielder Capital Group LLC purchased a new position in ASP Isotopes in the 2nd quarter worth about $55,000. KKM Financial LLC lifted its stake in ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after acquiring an additional 9,000 shares during the period. Sanctuary Advisors LLC bought a new position in ASP Isotopes during the 3rd quarter valued at about $66,000. Finally, MetLife Investment Management LLC bought a new stake in shares of ASP Isotopes in the third quarter worth approximately $88,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Stock Up 10.6 %

Shares of ASPI traded up $0.53 on Friday, hitting $5.55. 3,833,717 shares of the stock traded hands, compared to its average volume of 1,796,681. The company has a market capitalization of $396.21 million, a PE ratio of -8.87 and a beta of 3.88. ASP Isotopes has a one year low of $1.65 and a one year high of $9.33. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The business has a 50 day simple moving average of $5.21 and a 200 day simple moving average of $3.92.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.